Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone for Neuroprotection in Acute Ischemic Stroke with Hyperglycemia
NCT02195791Phase 2Terminated
- Sponsor
- Taipei Medical University Shuang Ho Hospital
- Start
- Jul 2014
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pioglitazone in ischemic stroke, sponsored by Taipei Medical University Shuang Ho Hospital. Started Jul 2014; status: terminated.
02
Drugs
pioglitazone
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02195791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02195791.